Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders

AB Biotek100 enrolled

Overview

Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

100

Conditions

Diarrhoea of Diverse Aetiology Requiring Oral Rehydration Therapy Diarrhoea and Gastrointestinal Symptoms Secondary to Enteral Nutrition

Interventions

ABB S3DIETARY_SUPPLEMENT

Postbiotic ABB S3 for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition

ABB C22DIETARY_SUPPLEMENT

Oral Rehydration Solution containing postbiotics ABB C22 for the management of diarrhoea signs of dehydration

PlaceboDIETARY_SUPPLEMENT

Placebo for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Inpatients of the centre * Diagnostic of diarrhoea: increase in daily faecal weight \> 200 g (as per the Centre protocol). * Subjects who as per the Centre protocol require Oral rehydration therapy * Patients with the ability to take the study product orally Exclusion Criteria: * History of allergy, idiosyncrasy, hypersensitivity or adverse reactions to the active principle or to any of the excipients. * History or evidence of any medical conditions or medication used that, in the opinion of the principal investigator, could affect the safety of the subjects or interfere with the study evaluations * Patients in situation of last days * Amytriptilin and masalazine treatment (anti-depressives) * Laxatives

Locations (1)

Isabel Roig

Barcelona, Barcelona, Spain